S. Rejno and B. Stromberg, Osteochondrosis in the Horse, II. Pathology. Acta Radiologica-Supplement, vol.358, pp.153-178, 1978.

B. Ytrehus, C. S. Carlson, and S. Ekman, Etiology and Pathogenesis of Osteochondrosis, Veterinary Pathology, vol.44, pp.429-448, 2007.

D. R. Verwilghen, S. Janssens, V. Busoni, F. Pille, C. Johnston et al., Do Developmental Orthopaedic Disorders Influence Future Jumping Performances in Warmblood Stallions?, Equine Veterinary Journal, vol.45, pp.578-581, 2013.

C. W. Mcilwraith, Inferences from Referred Clinical Cases of Osteochondritis Dissecans, Equine Veterinary Journal, vol.25, pp.27-30, 1993.

L. B. Jeffcott, Osteochondrosis in the Horse-Searching for the Key to Pathogenesis, Equine Veterinary Journal, vol.23, pp.331-338, 1991.

D. Serteyn, D. Piquemal, L. Vanderheyden, J. P. Lejeune, D. Verwilghen et al., Gene Expression Profiling from Leukocytes of Horses Affected by Osteochondrosis, Journal of Orthopaedic Research, vol.28, pp.965-970, 2010.

J. Power, P. Hernandez, J. Wardale, and F. M. Henson, Alterations in Sclerostin Protein in Lesions of Equine Osteochondrosis, Veterinary Record Open, vol.1, pp.5-000005, 2014.

P. Dijke, C. Krause, D. J. De-gorter, C. W. Lowik, and R. L. Van-bezooijen, Osteocyte-Derived Sclerostin Inhibits Bone Formation: Its Role in Bone Morphogenetic Protein and Wnt Signaling, Journal of Bone and Joint Surgery, vol.90, issue.S1, pp.31-35, 2008.

M. J. Moester, S. E. Papapoulos, C. W. Lowik, and R. L. Van-bezooijen, Sclerostin: Current Knowledge and Future Perspectives, Calcified Tissue International, vol.87, pp.99-107, 2010.

B. Y. Chan, E. S. Fuller, A. K. Russell, S. M. Smith, M. M. Smith et al.,

J. F. Sambrook, P. N. Little, and C. B. , Increased Chondrocyte Sclerostin May Protect against Cartilage Degradation in Osteoarthritis, Osteoarthritis and Cartilage, vol.19, pp.874-885, 2011.

A. Gaudio, F. Privitera, K. Battaglia, V. Torrisi, M. H. Sidoti et al., Sclerostin Levels Associated with Inhibition of the Wnt/Beta-Catenin Signaling and Reduced Bone Turnover in Type 2 Diabetes Mellitus, Journal of Clinical Endocrinology & Metabolism, vol.97, pp.3744-3750, 2012.

N. M. Appelman-dijkstra and S. E. Papapoulos, Novel Approaches to the Treatment of Osteoporosis, Best Practice & Research Clinical Endocrinology & Metabolism, vol.28, pp.843-857, 2014.

H. Zhang, J. W. He, C. Wang, Z. Zhang, H. Yue et al., Associations of Polymorphisms in the SOST Gene and Bone Mineral Density in Postmenopausal Chinese Women, Osteoporosis International, vol.25, pp.2797-2803, 2014.

K. Brabnikova-maresova, K. Jarosova, K. Pavelka, and J. J. Stepan, Serum Sclerostin in Adult High-Activity Patients with Juvenile Idiopathic Arthritis, Arthritis Research & Therapy, vol.16, p.460, 2014.

J. M. Denoix, S. Jacquet, J. Lepeule, N. Crevier-denoix, J. P. Valette et al., Radiographic Findings of Juvenile Osteochondral Conditions Detected in 392 Foals Using a Field Radiographic Protocol, The Veterinary Journal, vol.197, pp.44-51, 2013.

U. I. Modder, K. A. Hoey, S. Amin, L. K. Mccready, S. J. Achenbach et al., Relation of Age, Gender, and Bone Mass to Circulating Sclerostin Levels in Women and Men, Journal of Bone and Mineral Research, vol.26, pp.373-379, 2011.

D. Hilla and O. Distl, Heritabilities and Genetic Correlations between Fetlock, Hock and Stifle Osteochondrosis and Fetlock Osteochondral Fragments in Hanoverian Warmblood Horses, Journal of Animal Breeding and Genetics, vol.131, pp.71-81, 2014.

B. Dawson-hughes, S. S. Harris, L. Ceglia, and N. J. Palermo, Serum Sclerostin Levels Vary with Season, Journal of Clinical Endocrinology & Metabolism, vol.99, pp.149-152, 2014.

L. Vander-heyden, J. P. Lejeune, I. Caudron, J. Detilleux, C. Sandersen et al., Association of Breeding Conditions with Prevalence of Osteochondrosis in Foals, Veterinary Record, vol.172, p.68, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01019097

C. Robert, J. P. Valette, S. Jacquet, J. Lepeule, and J. M. Denoix, Study Design for the Investigation of Likely Aetiological Factors of Juvenile Osteochondral Conditions (JOCC) in Foals and Yearlings, The Veterinary Journal, vol.197, pp.36-43, 2013.
URL : https://hal.archives-ouvertes.fr/hal-02648599

J. Lepeule, N. Bareille, C. Robert, J. P. Valette, S. Jacquet et al., Association of Growth, Feeding Practices and Exercise Conditions with the Severity of the Osteoarticular Status of Limbs in French Foals, The Veterinary Journal, vol.197, pp.65-71, 2013.
URL : https://hal.archives-ouvertes.fr/hal-02650304

D. Serteyn, D. Piquemal, L. Mendoza, I. Caudron, F. Noguier et al., Osteochondrosis-Related Gene Expression in Equine Leukocytes Differs among Affected Joints in Foals, Journal of Molecular Biomarkers & Diagnosis, vol.5, p.189, 2014.

L. Mendoza, D. Piquemal, J. P. Lejeune, L. Vander-heyden, F. Noguier et al., Age-Dependent Expression of Osteochondrosis-Related Genes in Equine Leukocytes, Veterinary Record, 2014.

C. Desjardin, A. Vaiman, X. Mata, R. Legendre, J. Laubier et al., Next-Generation Sequencing Identifies Equine Cartilage and Subchondral Bone miRNAs and Suggests Their Involvement in Osteochondrosis Physiopathology, BMC Genomics, vol.15, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01194112

H. Xu, J. Duan, D. Ning, J. Li, R. Liu et al., The Role of Wnt Signaling in Fracture Healing, BMB Reports, 2014.

R. Baron and G. Rawadi, Targeting the Wnt/Beta-Catenin Pathway to Regulate Bone Formation in the Adult Skeleton, Endocrinology, vol.148, pp.2635-2643, 2007.

A. Garcia-martin, P. Rozas-moreno, R. Reyes-garcia, S. Morales-santana, B. Garcia-fontana et al., Circulating Levels of Sclerostin Are Increased in Patients with Type 2 Diabetes Mellitus, Journal of Clinical Endocrinology & Metabolism, vol.97, pp.234-241, 2012.

T. Klangjareonchai and H. Nimitphong, Circulating Sclerostin and Irisin Are Related and Interact with Gender to Influence Adiposity in Adults with Prediabetes, International Journal of Endocrinology, 2014.

C. Desjardin, S. Chat, M. Gilles, R. Legendre, J. Riviere et al., Involvement of Mitochondrial Dysfunction and ER-Stress in the Physiopathology of Equine Osteochondritis Dissecans (OCD), Experimental and Molecular Pathology, vol.96, pp.328-338, 2014.
URL : https://hal.archives-ouvertes.fr/hal-00973739

J. C. Yoon, A. Ng, B. H. Kim, A. Bianco, R. J. Xavier et al., Wnt Signaling Regulates Mitochondrial Physiology and Insulin Sensitivity, Genes & Development, vol.24, pp.1507-1518, 2010.

A. G. Robling, P. J. Niziolek, L. A. Baldridge, K. W. Condon, M. R. Allen et al., Mechanical Stimulation of Bone in Vivo Reduces Osteocyte Expression of Sost/Sclerostin, The Journal of Biological Chemistry, vol.283, pp.5866-5875, 2008.

S. Reppe, A. Noer, R. M. Grimholt, B. V. Halldorsson, C. Medina-gomez et al., Methylation of Bone SOST, Its mRNA, and Serum Sclerostin Levels Correlate Strongly with Fracture Risk in Postmenopausal Women, Journal of Bone and Mineral Research, 2014.

J. Delgado-calle, J. Arozamena, J. Perez-lopez, A. Bolado-carrancio, C. Sanudo et al., Role of BMPs in the Regulation of Sclerostin as Revealed by an Epigenetic Modifier of Human Bone Cells, Molecular and Cellular Endocrinology, vol.369, pp.27-34, 2013.